(LYMS) Amundi Nasdaq-100 II Acc - Ratings and Ratios

The Amundi Nasdaq-100 II UCITS ETF Acc EUR, traded on XETRA under the ticker symbol LYMS, is an exchange-traded fund that tracks the Morningstar US Large-Mid Broad Growth NR USD index. This ETF is designed to provide investors with exposure to US large-cap growth equities, comprising companies that exhibit strong growth characteristics.

As a Germany-originated ETF, LYMS is structured to comply with UCITS regulations, making it accessible to a broad range of investors across Europe. The fund accumulates dividends, reinvesting them to maximize long-term growth potential. With Assets Under Management (AUM) of approximately €1.23 billion, LYMS has achieved a significant scale, potentially benefiting from economies of scale in terms of cost efficiency.

Analyzing the technical data, the current price of LYMS is €76.28, slightly below its 20-day Simple Moving Average (SMA) of €76.58, indicating a neutral short-term trend. However, it is above its 50-day SMA of €72.33, suggesting a positive medium-term outlook. The 200-day SMA at €76.62 is just above the current price, implying a potential resistance level. The Average True Range (ATR) of 1.18, or 1.55%, indicates moderate volatility.

Considering the fundamental and technical data, a forecast for LYMS can be derived. Given its tracking of the Morningstar US Large-Mid Broad Growth NR USD index, the performance of LYMS is closely tied to the growth prospects of large-cap US companies. Historically, the Nasdaq-100 index, which LYMS closely relates to, has shown a strong growth trajectory, driven by technology and growth-oriented sectors. Assuming this trend continues, and with the current price below the 200-day SMA, there is potential for LYMS to regain its upward momentum. However, the moderate volatility indicated by the ATR suggests that investors should be prepared for fluctuations.

Based on the analysis, a potential forecast for LYMS could involve a short-term consolidation phase, followed by an upward trend if the tracked index continues its growth pattern. Investors should monitor the 200-day SMA as a key resistance level and be aware of the overall market conditions affecting US large-cap growth equities. A break above €76.62 could signal further upside potential, while a drop below €72.33 might indicate a more significant correction.